6BFD
BACE crystal structure with hydroxy pyrrolidine inhibitor
Summary for 6BFD
Entry DOI | 10.2210/pdb6bfd/pdb |
Descriptor | Beta-secretase 1, 2-{[(2S)-butan-2-yl]amino}-N-{(1R,2S)-1-hydroxy-3-phenyl-1-[(2R)-pyrrolidin-2-yl]propan-2-yl}-6-(methylsulfonyl)pyridine-4-carboxamide, GLYCEROL, ... (4 entities in total) |
Functional Keywords | bace1, beta-secretase, inhibitor, protease, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Membrane; Single-pass type I membrane protein: P56817 |
Total number of polymer chains | 2 |
Total formula weight | 99257.84 |
Authors | Timm, D.E. (deposition date: 2017-10-26, release date: 2017-11-15, Last modification date: 2017-12-27) |
Primary citation | Bueno, A.B.,Agejas, J.,Broughton, H.,Dally, R.,Durham, T.B.,Espinosa, J.F.,Gonzalez, R.,Hahn, P.J.,Marcos, A.,Rodriguez, R.,Sanz, G.,Soriano, J.F.,Timm, D.,Vidal, P.,Yang, H.C.,McCarthy, J.R. Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences. J. Med. Chem., 60:9807-9820, 2017 Cited by PubMed: 29088532DOI: 10.1021/acs.jmedchem.7b01304 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.62 Å) |
Structure validation
Download full validation report